Services

In addition to its internal research and development programs, BG Medicine collaborates with partners in the biotechnology, pharmaceutical and regulatory communities to address important R&D challenges in drug discovery and development. BG Medicine brings together unique experience across diverse disease and therapeutic areas, premier molecular analysis capabilities, proprietary databases of molecular identification and function, and a proven track record in providing solutions to partners.

BG Medicine’s molecular measurement and bioinformatics capabilities span the drug discovery and development continuum from preclinical experiments to translational medicine to clinical studies. A thorough biomolecular understanding of disease and the effects of pharmacological intervention is crucial to a successful discovery and development effort.

BG Medicine Services enable partners to:

• Advance compounds into clinical development with improved understanding of mode of action, efficacy, and on- and off-target effects
• Identify and validate biomarkers and companion diagnostics for your development program
• Reduce failure rates at all stages of the drug development pipeline
• Integrate proteomic, metabolomic and transcriptomic data

BG Medicine has successfully completed projects with multiple biotechnology and pharmaceutical partners across the drug discovery and development pipeline. Our experience comprises multiple species, multiple tissue matrices and bodily fluid types, and many distinct diseases and therapeutic classes. Frameworks for partnering with BG Medicine include per-project collaborations, strategic partnerships, and more comprehensive research and development relationships.

Contact Dr. Rene Myers for additional information on how to leverage BG Medicine’s capabilities and expertise for your research and development programs.